AUGUST 2019CIOAPPLICATIONS.COM8C XOs today are challenged with creating a digital front door for our consumers. As the role evolves from operational IT to strategic partnerships with business and clinical realms, CXOs should become adept at horizon scanning of different emerging technologies and therapies that may change patient behavior and our relationship with consumers. DTx is one such emerging tech that could cause some disruption very shortly. Imagine your physician prescribing you a mobile app instead of a pill. Or a drug that comes with a companion mobile app that can optimize your medication. Do our current digital strategies support such transactions? These type of therapies are already a reality and are causing a lot of excitement in the provider, payer, and pharma world. Innovative health systems now use digital therapies as an adjunct to standard outpatient treatment for mental health, substance use disorder, chronic condition management, cognitive dysfunction, and a host of other interventions.Digital Therapeutics is a class of interventions that include software programs used independently or in concert with medications, devices, and other therapies to improve outcomes. The Primary function of these software-generated therapeutic interventions is to prevent, manage, or treat a medical disorder or disease. These therapies are developed following internationally-recognized design, quality, and manufacturing standards and are reviewed and approved by regulatory and compliance bodies as required. They also go through clinical validation processes that may include adequately-powered Randomized Controlled Trials with clinically meaningful outcomes. According to the Digital Therapeutics Alliance, each digital therapeutic corresponds to one of four categories based on its intended use and official product claims:1. Address a medical condition2. Manage or prevent a medical disorder or disease3. Optimize medication (an individual medication or class of pharmaceuticals)4. Treat a medical disease or disorderHere are a few up and coming startups and pharma company solutions that are worth noting - In the substance abuse intervention space, reSET and reSET-O from Pear therapeutics are targeting Substance Use Disorder and Opioid abuse, respectively. Delivering Cognitive Behavioral Therapy as an adjunct to a contingency management system for a specific "Take an app for that and see me in a month!" The Rise of Digital Therapeutics (DTx)IRSHAD SIDDIQUI MD, CHIEF HEALTH INFORMATION OFFICER, BLESSING HEALTH SYSTEMIrshad Siddiqui MDIN MY View
< Page 7 | Page 9 >